Thus, 300 days of survival in the absence of any signs of disease, combined with a lack of detectable human Alu sequences, indicated to us that the impact of NEO212 might indeed have been curative—and independent of the MGMT status of the tumor cells. The gene discussed is MGMT; the disease is neoplasm.